drugset / Trial / NCT05378074

Hypersensitivity to Opening of BKCa Channels in Post-Traumatic Headache

NCT05378074 ↗

Unknown 21 enrolled Danish Headache Center
RandomizedCrossoverQuadruple-blindBasic science

Summary

The aim is to investigate whether opening of large conductance calcium-activated potassium (BKCa) channels induces headache with migraine-like features in people with persistent post-traumatic headache (PTH) attributed to mild traumatic brain injury (mTBI).

Timeline

Start
2022-09-01
Primary completion
2023-12-31
Completion
2023-12-31

Outcome

Met primary endpoint

paper 11 (52%) of 21 participants after MaxiPost infusion, in contrast to four (19%) participants following placebo (P = .02). PMID 38890563 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject FLINDOKALNER Small molecule 0.05 mg Intravenous